Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy

Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy

Background. Treatment of intractable pain due to chemotherapy induced peripheral neuropathy (CIPN) is a challenge. Intravenous (iv) lidocaine has shown to be a treatment option for neuropathic pain of different etiologies. Methods. Lidocaine (1.5 mg/kg in 10 minutes followed by 1.5 mg/kg/h over 5 ho...

Full description

Bibliographic Details
Main Authors: Sandra A. S. van den Heuvel, Selina E. I. van der Wal, Lotte A. Smedes, Sandra A. Radema, Nens van Alfen, Kris C. P. Vissers, Monique A. H. Steegers
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2017/8053474

Internet

http://dx.doi.org/10.1155/2017/8053474

Similar Items